Jul 2026
Development of a mucosal vaccine for pan-Sarbecoviruses: a papilloma pseudovirus expressing SARS-CoV-2 M and N proteins 2259718
It is demonstrated that mucosal delivery of conserved CoV antigens via papillomavirus VLPs induces strong, antigen-specific T cell responses and protects against heterologous SARS-CoV-2 challenge and shows promise for developing a pan-coronavirus vaccine.
Aidan Dorn, Hansam Cho, Lanying Du et al.
· Journal of Immunology · 0 citations